发明名称 |
Method for determining clinically relevant hypoxia in cancer |
摘要 |
<p>The present invention provides a method for determining the oxygen status of a cancer of an individual. The method comprise determining the transcriptional expression level of ADM (SEQ ID No:1), and/or at least one gene selected from ANKRD37 (SEQ ID NO.: 3), P4HA2 (SEQ ID NO.: 12), NDRG1 (SEQ ID NO: 10), SLC2A1 (SEQ ID NO:15), P4HA1 (SEQ ID NO.: 11), LOX (SEQ ID NO.: 9), C3orf28 (SEQ ID NO.: 6), BNIP3L (SEQ ID NO.: 5), BNIP3 (SEQ ID NO.:4), EGLN3 (SEQ ID NO.: 7), PDK1 (SEQ ID NO.: 13), PFKFB3 (SEQ ID NO.: 14), KCTD11 (SEQ ID NO.: 8), and/or ALDOA (SEQ ID NO.: 2), in a cancer sample. The transcriptional level is then correlated to the transcriptional level to at least one reference gene, and oxygen status10 is then evaluated by comparing the correlated transcription level with a predetermined reference sample comprising cancer cells characterized by a high oxygen level.</p> |
申请公布号 |
AU2012247868(A1) |
申请公布日期 |
2013.11.14 |
申请号 |
AU20120247868 |
申请日期 |
2012.04.30 |
申请人 |
NORDSMARK, MARIANNE;ALSNER, JAN;WIUF, CARSTEN;SORENSEN, BRITA;TOUSTRUP, KASPER;OVERGAARD, JENS |
发明人 |
OVERGAARD, JENS;SORENSEN, BRITA SINGERS;ALSNER, JAN;WIUF, CARSTEN;NORDSMARK, MARIANNE;TOUSTRUP, KASPER |
分类号 |
C12Q1/68;A61K31/415;A61K31/4164 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|